For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab93686? Please let us know so that we can cite the reference in this datasheet.
ab93686 has been referenced in 1 publication.
- Watanabe K et al. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer. J Biol Chem 291:20891-20899 (2016).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"